UY40135A - Inhibidores peptídicos del receptor de interleucina-23 y composiciones farmacéuticas de estos - Google Patents

Inhibidores peptídicos del receptor de interleucina-23 y composiciones farmacéuticas de estos

Info

Publication number
UY40135A
UY40135A UY0001040135A UY40135A UY40135A UY 40135 A UY40135 A UY 40135A UY 0001040135 A UY0001040135 A UY 0001040135A UY 40135 A UY40135 A UY 40135A UY 40135 A UY40135 A UY 40135A
Authority
UY
Uruguay
Prior art keywords
interleukin
receptor
pharmaceutical compositions
peptide inhibitors
solvates
Prior art date
Application number
UY0001040135A
Other languages
English (en)
Spanish (es)
Inventor
Philippe Fernandes
Gopal Rajan
Di Pretoro Giustino
Dajun Sun
Geraldine Broeckx
Nathalie Mertens
T Breslin David
Anduix Canto Clara
Paul Dobbelaere Christopher
Gildas Deniau
Ruzica Kolakovic
Lomstein Pedersen Betty
Sejal Patel
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of UY40135A publication Critical patent/UY40135A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
UY0001040135A 2022-02-01 2023-02-01 Inhibidores peptídicos del receptor de interleucina-23 y composiciones farmacéuticas de estos UY40135A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202263305631P 2022-02-01 2022-02-01

Publications (1)

Publication Number Publication Date
UY40135A true UY40135A (es) 2023-08-31

Family

ID=85556753

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001040135A UY40135A (es) 2022-02-01 2023-02-01 Inhibidores peptídicos del receptor de interleucina-23 y composiciones farmacéuticas de estos

Country Status (13)

Country Link
EP (1) EP4472999A1 (https=)
JP (1) JP2025506374A (https=)
KR (1) KR20240137102A (https=)
CN (1) CN118829647A (https=)
AU (1) AU2023215245A1 (https=)
CA (1) CA3250172A1 (https=)
CL (1) CL2024002263A1 (https=)
IL (1) IL314629A (https=)
MX (1) MX2024009477A (https=)
PE (1) PE20241895A1 (https=)
TW (1) TW202342496A (https=)
UY (1) UY40135A (https=)
WO (1) WO2023150500A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL322423A (en) 2023-01-31 2025-09-01 Janssen Pharmaceutica Nv Methods for preparing crystalline peptide inhibitors of the interleukin-23 receptor
WO2025062347A1 (en) * 2023-09-21 2025-03-27 Janssen Pharmaceutica Nv Interleukin-23 receptor antagonist for use in the treatment of ulcerative colitis
WO2025151385A1 (en) * 2024-01-08 2025-07-17 Janssen Pharmaceutica Nv Peptide inhibitors of interleukin-23 receptor and uses thereof
WO2025163534A1 (en) * 2024-01-31 2025-08-07 Janssen Pharmaceutica Nv Crystal form of a peptide inhibitor of interleukin-23 receptor
WO2025243217A1 (en) * 2024-05-22 2025-11-27 Janssen Pharmaceutica Nv Crystal forms of peptide molecules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8946150B2 (en) 2011-06-14 2015-02-03 Medical Diagnostic Laboratories, LLC. Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
CA3167751A1 (en) 2020-01-15 2021-07-22 Janssen Biotech, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases

Also Published As

Publication number Publication date
TW202342496A (zh) 2023-11-01
IL314629A (en) 2024-09-01
CA3250172A1 (en) 2023-08-10
CN118829647A (zh) 2024-10-22
EP4472999A1 (en) 2024-12-11
KR20240137102A (ko) 2024-09-19
CL2024002263A1 (es) 2025-02-07
MX2024009477A (es) 2024-11-08
PE20241895A1 (es) 2024-09-19
WO2023150500A1 (en) 2023-08-10
JP2025506374A (ja) 2025-03-11
AU2023215245A1 (en) 2024-09-19

Similar Documents

Publication Publication Date Title
CO2023007172A2 (es) Composiciones de inhibidores peptídicos del receptor de interleucina-23
DOP2022000147A (es) Inhibidores de péptidos del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias
MX2024009477A (es) Inhibidores peptídicos del receptor de interleucina-23 y composiciones farmacéuticas de estos
DOP2024000011A (es) Inhibidores peptídicos lipídicos del receptor de interleucina-23
MX2022008740A (es) Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias.
MX2024000762A (es) Inhibidores peptidicos del receptor de interleucina-23.
AR119389A1 (es) Inhibidores de péptidos del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias
UY39858A (es) Inhibidores peptídicos bicíclicos del receptor de interleucina-23
BR112022000328A2 (pt) Inibidores peptídicos do receptor de interleucina-23 e seu uso para tratar doenças inflamatórias
CL2018003322A1 (es) Inhibidores peptídicos del receptor de interleucina 23 y sus uso para tratar enfermedades inflamatorias. (divisional solicitud 201800128)
CL2023002223A1 (es) Inhibidores de cdk2 y métodos de uso de los mismos
MX2025001224A (es) Inhibidores de kit, compuestos, composiciones farmaceuticas y metodos de uso de los mismos
UY40134A (es) Motor de presión negativa
DOP2025000151A (es) Inhibidores peptídicos del receptor de interleucina-23
CO2025010249A2 (es) Inhibidores peptídicos del receptor de interleucina-23
MX2025008922A (es) Metodos para preparar inhibidores peptidicos cristalinos del receptor de interleucina-23